Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors.

In this article, we'll explore the seven most common obstacles to joining clinical trials and offer strategies to overcome ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

A neurologist from Sheffield Teaching Hospitals NHS Foundation Trust has won a local clinical research investigator award for ...

Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for ...

A groundbreaking device designed to prevent strokes is currently undergoing clinical trials at the TriHealth Heart and ...

Medcura, Inc., a leader in innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding, has announced the formation of its Spinal Surgery Advisory Board.

New findings show that cortisol rises before waking, not after, as part of the body’s natural circadian rhythm.

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...

Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial ...

Rutgers Health researchers find that allergy medicine could help patients with a rare genetic disease avoid liver transplants ...